VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 356 filers reported holding VALEANT PHARMACEUTICALS INTL in Q2 2016. The put-call ratio across all filers is 1.00 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $1,178,000 | -84.9% | 44,801 | -41.6% | 0.20% | -83.8% |
| Q4 2015 | $7,802,000 | +148.5% | 76,756 | +336.0% | 1.23% | +140.0% |
| Q3 2015 | $3,140,000 | -6.4% | 17,603 | +16.5% | 0.51% | +8.2% |
| Q2 2015 | $3,356,000 | -47.2% | 15,105 | -52.8% | 0.47% | -40.6% |
| Q1 2015 | $6,354,000 | +3.8% | 31,990 | -25.2% | 0.80% | -4.4% |
| Q4 2014 | $6,120,000 | -8.6% | 42,763 | -16.2% | 0.83% | -40.9% |
| Q3 2014 | $6,699,000 | +1.7% | 51,057 | -2.2% | 1.41% | -7.8% |
| Q2 2014 | $6,584,000 | -9.8% | 52,203 | -5.8% | 1.53% | -12.9% |
| Q1 2014 | $7,302,000 | +19.2% | 55,391 | +6.1% | 1.76% | +14.2% |
| Q4 2013 | $6,127,000 | – | 52,185 | – | 1.54% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chou Associates Management | 1,648,992 | $38,323,000 | 14.52% |
| Paulson & Co. | 20,839,035 | $484,299,000 | 9.89% |
| MILLER VALUE PARTNERS, LLC | 4,999,064 | $116,178,000 | 4.34% |
| GoldenTree Asset Management | 1,140,205 | $26,498,000 | 4.21% |
| Pomelo Capital LLC | 1,760,000 | $40,902,000 | 4.00% |
| Bruce & Co., Inc. | 860,000 | $19,986,000 | 3.98% |
| ValueAct Holdings | 18,033,149 | $419,090,000 | 3.79% |
| Stanley Capital Management, LLC | 318,400 | $7,400,000 | 3.25% |
| Kazazian Asset Management, LLC | 134,784 | $3,132,000 | 2.87% |
| Phoenix Investment Adviser LLC | 58,400 | $1,357,000 | 2.48% |